Skip to content

Evaluation the effect of probiotics on gastrointestinal symptoms in patients with gastric cancer

Evaluation the effect of probiotics on gastrointestinal symptoms in patients with gastric cancer

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211226053534N1
Enrollment
60
Registered
2022-02-19
Start date
2022-02-20
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gasteric cancer. Malignant neoplasm of stomach, unspecified

Interventions

Intervention 1: Intervention group: Probiotic capsule containing three strains of probiotic bacteria including Lactobacillus acidophilus, Bifidobacterium lactis and Bifidobacterium longum and is one

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age between 18 to 70 years Endoscopically confirmed gastric cancer and pathology that are in the recovery phase (their treatment is over) Refer to the gastroenterology clinic of Azad University of mashhad educational hospitals Informed consent to enter the study

Exclusion criteria

Exclusion criteria: Obvious neurological disease Probiotic consumption in the past month Dissatisfaction with inclusion in the study Lack of patient cooperation Lack of proper use of the Probiotic in both groups Sensitivity to the studied Probiotic Pregnant or lactating women Chronic users of non-steroidal anti-inflammatory drugs

Design outcomes

Primary

MeasureTime frame
VAS visual scale for Gastrointestinal symptoms such as abdominal pain, diarrhea, constipation and bloating. Timepoint: Before the intervention and at the end of the fourth and eighth weeks. Method of measurement: VAS visual scale.;. Timepoint: . Method of measurement: .

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Mokhtari Amirmajdi

Islamic Azad University

Emokhtaria@gmail.com+98 915 316 5096

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026